Medscape Medical NewsAll articles

SIS System

Surgical Information Sciences, Inc. • Radiology • 06/14/2024

510(k)IEC 62304 Class B§524B Cyber Device
FDA Summary PDF

Device Purpose

The SIS System is a medical image processing software designed to assist clinicians in neurological procedures, particularly Deep Brain Stimulation, by providing enhanced visualization and localization of specific deep brain structures including the STN, GPe, GPi, and the newly added Vim. It utilizes machine learning, specifically pre-trained deep learning neural networks trained with ultra-high resolution 7T MRI data as ground truth, to generate patient-specific 3D anatomical models from standard clinical MR images, aiding in stereotactic surgical planning.

Summary

The SIS System, developed by Surgical Information Sciences, Inc., is an advanced medical imaging software intended for the viewing, presentation, and documentation of medical images. It facilitates image processing, image fusion, and intraoperative functional planning, with its 3D output usable in stereotactic image-guided surgery or with other devices for further processing and localization. Specifically, the system aids medical professionals like surgeons, neurologists, and radiologists in visualizing and locating deep brain structures such as the subthalamic nuclei (STN), globus pallidus externa and interna (GPe/GPi), and the ventral intermediate nucleus (Vim) during neurological procedures, including Deep Brain Stimulation (DBS) lead placement. This version represents a modification to a previously existing system, primarily adding support for Vim visualization. The core technology of the SIS System is based on machine learning and image processing, employing pre-trained deep learning neural network models to enhance standard clinical MR images (1.5T and 3T). These models are trained using ultra-high resolution 7T Magnetic Resonance (MR) images to establish ground truth, enabling the generation of patient-specific 3D anatomical models of the targeted brain structures. The system can also identify implanted leads from post-operative CT images and correlate their positions with pre-operative brain structure models. Performance validation for the new Vim visualization feature involved comparing SIS outputs against ground truth segmentations (derived from clinical MRI, 7T MRI, and DiMANI). The validation demonstrated high accuracy, with 90% of center of mass distances for Vim below 1.83mm, 90% of mean surface distances below 0.86mm, and a mean Dice coefficient of 0.7, meeting pre-specified criteria.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

SIS SystemMedical Image ProcessingMachine LearningDeep Learning ModelsNeurological ProceduresDeep Brain StimulationVentral Intermediate Nucleus (Vim)Stereotactic Image Guided Surgery7T MRI3D Anatomical Model

Device Metadata

Submission Number
K241083
Company
Surgical Information Sciences, Inc.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Intervention
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How robust is the SIS System's Vim visualization to variations in input clinical MRI scanner manufacturers, field strengths (1.5T vs. 3T), and acquisition protocols, beyond the tested datasets?; What are the specific advantages and limitations of using DiMANI for ground truth segmentation of the Vim compared to direct manual segmentation on 7T MRI in the context of training and validating the deep learning models?; How does the system handle cases with significant brain anatomical abnormalities or prior surgical interventions that might affect the typical appearance or location of the targeted nuclei?; What is the computational time required for the SIS System to process a typical patient dataset and generate the 3D model of the Vim, and how does this integrate into a typical clinical workflow for surgical planning?; Are there plans to expand the SIS System's capabilities to include other subcortical structures relevant to neurological disorders or to integrate other imaging modalities beyond MRI and CT for model generation or validation?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment⚠ Not in summary - likely in full submission per §524B
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, deep learning, neural network, dataset, ground truth)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
SIS System - Surgical Information Sciences, Inc. | ESL FDA AI Device Intelligence